How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?

by Philippe Colucci, Jacques Turgeon, Murray P. Ducharme
Published 2011-06-01

Rethinking bioequivalence and equivalence requirements of orally inhaled drug products

by Dina Al-Numani, Philippe Colucci, Murray P. Ducharme
Published 2015-12-01

Revisiting FDA’s 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations

by Deniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, Philippe Colucci, Isadore Kanfer, Murray P. Ducharme
Published 2018-11-01